Market Place
Sourcing Support
Cyxone Streamlines Manufacturing Process for Rabeximod
09 Mar 2023 //
CONTRACT PHARMA
Nomination committee appointed for Cyxone Annual General Meeting 2023
08 Nov 2022 //
IPOHUB
Cyxone will leverage IND and use FDA pre-review for Covid-19 phase 2 trial
24 Sep 2021 //
CISION
Cyxone & Medical University of Vienna announce collaboration to study T20K
01 Jul 2021 //
CISION
Cyxone Initiates Feasibility Preclinical Studies to Multiple Sclerosis
06 May 2021 //
CISION
Cyxone reports first Covid-19 screened in Ph2 trial of Rabeximod
15 Jan 2021 //
PRNEWSWIRE
Cyxone has filed an IND in the US with Rabeximod following positive feed-back
15 Dec 2020 //
PRNEWSWIRE
Cyxone to begin Phase II trial of oral Covid-19 drug
09 Dec 2020 //
CLINICALTRIALSARENA
Cyxone receives regulatory approval to initiate a clinical Phase 2 study
08 Dec 2020 //
PRNEWSWIRE
Cyxone files patent application to extend exclusivity of Rabeximod
10 Nov 2020 //
PRNEWSWIRE
Cyxone revises the development plan for Rabeximod
24 Sep 2020 //
PRNEWSWIRE
Cyxone to initiate a phase 2 clinical trial with Rabeximod in Covid-19 patients
14 Sep 2020 //
PRNEWSWIRE
Cyxone Signs Agreement With Professor Rikard Holmdahl as Senior Scientific
08 Jul 2020 //
PRNEWSWIRE
Cyxone Signs Agreement With Professor Rikard Holmdahl as Senior Scientific
08 Jul 2020 //
PRNEWSWIRE
Cyxone Signs Agreement With Dr Maarten Kraan as Senior Scientific Advisor
06 Jul 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.